Showing results (321-330 of 338) with videos related to
Sort By:
Pageof 34
Bioorganic & Medicinal Chemistry Letters|February 17, 2005
Glucokinase-activating ureasArlindo L Castelhano, Hanqing Dong, Matthew C T Fyfe, et al.Drug Discovery Today|August 3, 2013
Fragment-based hit identification: thinking in 3DAndrew D Morley, Angelo Pugliese, Kristian Birchall, et al.Artificial Organs|August 27, 1999
Chronic survival of calves implanted with the DeBakey ventricular assist deviceT W Fossum, D Morley, R Benkowski, et al.Bioorganic & Medicinal Chemistry Letters|June 15, 2011
Selective non zinc binding inhibitors of MMP13Chris De Savi, Andrew D Morley, Attilla Ting, et al.Bioorganic & Medicinal Chemistry Letters|May 3, 2005
Structure-based design of protein tyrosine phosphatase-1B inhibitorsEmma Black, Jason Breed, Alexander L Breeze, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 11, 2014
Trastuzumab-associated cardiac events at 8 years of median follow-up in the Herceptin Adjuvant trial (BIG 1-01)Evandro de Azambuja, Marion J Procter, Dirk J van Veldhuisen, et al.Thorax|April 30, 2020
Serial CT analysis in idiopathic pulmonary fibrosis: comparison of visual features that determine patient outcomeJoseph Jacob, Leon Aksman, Nesrin Mogulkoc, et al.Biorxiv : the Preprint Server for Biology|February 19, 2024
MAGIC matrices: freeform bioprinting materials to support complex and reproducible organoid morphogenesisAustin J Graham, Michelle W L Khoo, Vasudha Srivastava, et al.Nature Communications|July 12, 2019
Quantitative characterization of 3D bioprinted structural elements under cell generated forcesCameron D Morley, S Tori Ellison, Tapomoy Bhattacharjee, et al.Journal of Medicinal Chemistry|July 1, 2008
SAR, pharmacokinetics, safety, and efficacy of glucokinase activating 2-(4-sulfonylphenyl)-N-thiazol-2-ylacetamides: discovery of PSN-GK1Lisa S Bertram, Daniel Black, Paul H Briner, et al.Pageof 34